A Study to Compare the Efficacy and Safety of Intravenous Iron Sucrose and Intramuscular Iron Sorbitol Therapy for Anemia During Pregnancy

摘要

Aims and Objectives To compare the efficacy, safety, and rate of response of intravenous iron sucrose and intramuscular iron sorbitol therapy for anemia during pregnancy. Material and Methods 100 antenatal cases of gestational age 14–32?weeks were included in this prospective study. Cases were randomly divided into two groups. Group A, having 50 cases received intravenous iron sucrose, and 50 cases in Group B received intramuscular iron sorbitol. Response to therapy in both groups was studied and compared. Results The mean pretherapy hemoglobin in group A was 6.49?gm/dl and in group B was 6.48?gm/dl. The rise in hemoglobin after 4?weeks of starting therapy was 3.52?gm/dl in group A and 2.33?gm/dl in group B. The difference was statistically significant ( P